"DE - Spolkov\u00E1 republika N\u011Bmecko" . . "Confavreux, C." . . "Rudick, R. A." . . . "0340-5354" . "Panzara, M. A." . "V" . "Lynn, F." . . "Hutchinson, M." . . "Phillips, JT" . "Stuart, W. H." . "Wynn, DR" . "Radue, E. W." . "The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL" . . "Galetta, SL" . . "O'Connor, PW" . . . . "[4D84EAF8A249]" . . . "Lublin, FD" . "1"^^ . "The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL"@en . "Kappos, L." . "3" . . . "RIV/00064165:_____/09:3944" . . . "The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL" . "The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL"@en . "11"^^ . "Miller, DH" . . "Polman, C. H." . "The AFFIRM and SENTINEL studies showed that natalizumab was effective both as monotherapy and in combination with interferon beta (IFN beta)-1a in patients with relapsing multiple sclerosis (MS)." . "256" . "RIV/00064165:_____/09:3944!RIV10-MZ0-00064165" . "312475" . . "Weinstock-Guttman, B." . . "Wajgt, A." . . "Calabresi, P. A." . . "Havrdov\u00E1, Eva" . . "The AFFIRM and SENTINEL studies showed that natalizumab was effective both as monotherapy and in combination with interferon beta (IFN beta)-1a in patients with relapsing multiple sclerosis (MS)."@en . . "20"^^ . "Journal of Neurology" . "Multiple sclerosis; natalizumab; interferon beta-1a; subgroup analysis; highly active relapsing multiple sclerosis; placebo-controlled trial; double-blind; interferon beta-1a; predictive value; natural-history; disability; integrin; multicenter; pathogenesis; progression"@en . "Giovannoni, G." . . "000265732800014" .